What is the pharmaceutical supply chain
What is the pharmaceutical supply chain, any industry has a complete supply chain, the pharmaceutical industry is no exception, at present, with the Internet big data as a technical means, the pharmaceutical industry has formed a relatively complete ecological chain system to realize the needs of hospitals, doctors, patients in the circulation of drugs, the following details of the pharmaceutical supply chain is.
What is the pharmaceutical supply chain1The essence of the pharmaceutical supply chain is the flow of pharmaceutical products or related services from the supplier to the consumer, with the aim of improving the performance of the pharmaceutical and healthcare service delivery sector, while reducing the cost of the pharmaceutical supply chain. The main node members of the pharmaceutical supply chain include new drug development departments, raw material suppliers, manufacturers, distributors, healthcare service delivery departments (hospitals and clinics, etc.), and final consumers.
On the one hand, due to the wide range of drug specifications, varieties, and batches, different drugs have different requirements for production, distribution, storage, and sales. On the other hand, the pharmaceutical supply chain is involved in more subjects, in addition to new drug research and development departments, raw material suppliers, manufacturers, distributors, hospitals and other healthcare service delivery departments, as well as the government, insurance agencies, drug purchasing organizations (GPOs), etc., the interaction and influence of the different subjects increase the supply of pharmaceuticals
I. On the Pharmaceutical Logistics Five prospects for the future and development:
1. Ecological **** enjoyment platform. The future of the pharmaceutical supply chain should be the information platform, commercial banks, the enterprise sector drug supervision and management departments, consumers and other elements of the combination, *** build an efficient ecosystem.
2. Organizational structure grid. Pharmaceutical supply chain enterprises should be from a single linear structure, to a dynamic mesh topology.
3. Service level specialization. With the implementation of the sub-diagnosis and treatment system, the hospital's functional positioning is more accurate, and the requirements for specialized pharmaceutical logistics services are more reliable.
4. Pharmaceutical logistics standardization. Enhancing the standardization of pharmaceutical logistics is closely related to improving the quality of logistics services, operational efficiency, and reducing logistics costs.
5. Information technology intelligence. Pharmaceutical supply chain and the deep integration of the Internet, business boundaries are broken, information technology to force the industry chain to strengthen the supply chain synergy.
2. Which are the main methods of supply chain management:
Methods of Supply Chain Management I: Effective cost reduction management methods. For the supply, cost is a problem, can effectively reduce costs, for supply chain management is of great significance, especially some of the need for inventory supply chain management, more should be done to effectively reduce costs.
Supply chain management method two: quickly meet market demand. No matter what kind of industry or field, supply chain management is essential, as a manager we need to have the ability to quickly meet market demand, such as the supermarket system, once the customer found that the demand for a particular product is particularly large, particularly urgent, can quickly meet the customer in the supply side.
Supply chain management method three: make full use of the role of labor. Labor is **direct and often **effective, supply chain management is the same, can make full use of labor, not waste labor is **management methods.
What is the pharmaceutical supply chain2The extension of the pharmaceutical supply chain also has some of its own insurmountable problems
Pharmaceutical SPD supply chain management refers to the supply of medical supplies in the hospital, inventory, processing, distribution and other work for the integration of the centralized logistics management services run, alternative to the hospital's traditional material management model, to enhance the Hospital medical material management efficiency, enhance the hospital operation modernization level, reduce the medical material management cost of a supply chain management services.
Now, this supply chain extension services, is characterized as hosting, called off.
Guangdong is one of the pioneers in exploring pharmacy reform, as early as 2016, 2017, there are 223 medical institutions (the end of 2018, Guangdong Provincial Health Commission to carry out mapping data), mainly in the form of pharmaceutical logistics supply chain extension, and 1-4 ranging from 1-4 pharmaceutical enterprises signed an agreement to carry out cooperation, the cooperation period of 5-8 years ranging. The pharmaceutical companies that provide cooperation are mainly Guangzhou Pharmaceutical Company Limited, Sinopharm Holding Company Limited, China Resources Pharmaceutical Company Limited, Kangmei Pharmaceutical Company Limited, General Pharmaceutical Company Limited, and ShangPharma Company Limited (all of the above including the subsidiaries of the city in which they are located).
But a few days ago, according to the health sector news, the Guangdong Provincial Health Commission previously issued a series of public medical institutions drug supply service self-check documents, Guangzhou City is clear that the drug supply chain extension services under the pharmacy hosting, expressly called off.
Medical equipment sink query the Guangdong Health Commission on June 25 in its official website published "on the CPPCC Twelfth Guangdong Provincial Committee of the second meeting of the proposal No. 20190671 reply letter", the text said "drug supply chain extension there are still some of their own insurmountable problems," the rumor was characterized hosting
In recent years, with the official "pharmacy hosting" caliber change of mouth, many listed pharmaceutical companies to find another way, such as the national drug, on the drug, Baiyunshan and other announcements disclosure of the drug, device supply chain extension services as a key project in cooperation with the hospital.
SPD services are not good or evil, the reason why the authorities suddenly called a halt, no doubt, hurt a party of the whole chain, "and the situation has been more serious."
Before the industry generally believe that this model does not exist to pay the hosting fee, purely just to the hospital to provide services in exchange for the market, in line with the direction of health care reform. But the landing of the past few years, but fell into the "crooked mouth monk read a crooked" situation. According to the health sector article, logistics and distribution companies after the distribution price war (generally winning the bid is a large circulation group), some people in order to longer cooperation (generally winning the bid 5-8 years, etc.), the commitment to come up with higher benefits and hospitals to rebuild a new chain of interests, and this part of the pressure on the profits were dumped to the drug companies, armament enterprises, triggering dissatisfaction and therefore be called off.
It is undeniable that, at present, public hospitals in the management of the prevailing emphasis on or to strengthen the clinical business management, neglect or weakening of the hospital operations management, poor inter-departmental synergies, the overall operating costs of the phenomenon of high; hospitals in the abolition of the drug markups, reduce the consumables revenue and other medical products revenue, if there is not enough financial compensation from the government, the hospital will be operating more and more difficult.
And SPD as a logistics platform, if you can solve the hospital's "last kilometer" delivery to the user's hand, undoubtedly for the hospital to reduce the burden of reducing the distribution costs. As the old saying goes, "Once monopolized, it's all about the fees", which really comes true. After all, the current SPD in-hospital logistics model of the winning bidder, often controlled by a few large pharmaceutical distribution companies.
When you want SPD, SPD on SPD, and now to hospitals, enterprises to separate, can really say that the points on the points?
This notice came out before the bidding of Guangzhou Pharmaceuticals, State Pharmaceuticals, Shanghai Pharmaceuticals, etc., is really a big summer splash of cool water. This Guangzhou SPD service was called off, that logistics companies and hospitals between the partnership will really quickly cut off?
Not very realistic, after all, before a price war, pharmaceutical distribution companies have invested real money to buy equipment, get software, and now 5-8 years of the contract to say stop, the enterprise heart also bitter. And to the hospital side, drugs, consumables distribution opened the sunroof, have to re-invest manpower, inability to solve. This time SPD called a halt, on the surface is really a lose-lose. But "stop, often for a better start".
At present, in addition to Guangzhou, SPD services in other provinces and cities are still in full swing. Guangzhou will be defined as hosting, stopping may be a temporary rectification, once the requirements and standards are met, and hosting to draw a clear line, and then resume business is not a bad thing.
What is the pharmaceutical supply chain3 The structural composition of the pharmaceutical supply chain Whether it is the traditional pharmaceutical supply chain, or under the two-ticket system and other health care reform of the pharmaceutical supply chain or the pharmaceutical supply chain digitalization, contains a number of nodes of supply chain subjects involved in the production of medicines from the end to a series of processes by the consumer: Pharmaceutical industry regulators, suppliers of raw and auxiliary materials, pharmaceutical manufacturers, pharmaceutical bidding intermediaries, pharmaceutical wholesalers, pharmaceutical distributors, hospitals, pharmaceutical retailers, partners (e.g., third-party logistics companies, banks, and other organizations), and end-customers (patients). In the pharmaceutical supply chain, it can be divided into two major segments, supply logistics and distribution logistics, according to the order and nature of occurrence. Supply logistics refers to the pharmaceutical production enterprises, raw materials as the object of transportation, warehousing, loading and unloading, handling, information processing and other logistics activities. It is characterized by fixed transport routes, large batch (if the road transport mode, the main vehicle), stable frequency. Sales logistics refers to the process from the finished product warehouse of the pharmaceutical company to the hands of consumers, to the finished drug as the object, from the pharmaceutical company to the retail terminal, contains two pieces of transportation of different nature: trunk transportation and regional distribution. Pharmaceutical supply chain in the 'involved in too many subjects, the public is more concerned about the sales side of the supply chain, the typical structure shown in the figure below. Typical structure of the pharmaceutical supply chain It can be said that the pharmaceutical supply chain is a complex and dynamic network, with the general supply chain network hierarchy **** nature. The node body in the middle of the pharmaceutical supply chain has both multiple suppliers and multiple downstream customers at the same time. Pharmaceutical Supply Pharmaceutical Supply Chain Nodes Structural Composition of the Main Body and Role Positioning Chain Pharmaceutical Manufacturing Enterprises Pharmaceutical manufacturing companies are at the source of the pharmaceutical supply chain as defined in this paper. The source of the pharmaceutical supply chain, and its downstream customers are pharmaceutical wholesalers and pharmaceutical retailers at all levels. Their main roles in the supply chain are: Firstly, to develop and produce qualified medicines needed by consumers and put them on the market for consumers to choose and use; Secondly, to provide downstream customers with real-time information on products and inventories to optimize supply chain costs and improve the quality of the supply chain. The second is to provide real-time product and inventory information to downstream customers to optimize supply chain costs and improve supply chain quality. Drug wholesalers Drug wholesalers are the intermediate link in the drug supply chain, which is both a gathering place and a dispersal place for drugs. On the one hand, it is closely connected with the upstream drug manufacturers, and obtains the object of business from drug manufacturers, on the other hand, it is inseparable from the downstream drug terminal sales places (hospitals, drug retailers), and provides them with products for disease prevention and treatment, rehabilitation and health care. Its main role in the supply chain is: First, it is responsible for the supply, distribution and allocation of medicines, providing hospitals and drug retailers with the medicines needed by patients; Second, it plays a key role in providing logistics, transportation, inventory management and information services for the pharmaceutical supply chain, which is a key link in the supply chain for ensuring the smooth flow of logistics and information flow and improving the operational efficiency of the entire supply chain.